Home › NDC Lookup › RxCUI directory › RxCUI 1011741

Aliskiren 300 MG Oral Tablet [Tekturna] — RxCUI 1011741

RxNorm drug concept · Semantic branded drug
RxCUI 1011741 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1011741
Official nameAliskiren 300 MG Oral Tablet [Tekturna]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTekturna 300 MG Oral Tablet
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aliskiren: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Aliskiren is used to lower high blood pressure — that's its one approved use. By controlling your blood pressure, it helps reduce your risk of serious events like stroke and heart...
  • What exactly is aliskiren (Tekturna) used for?
  • What matters most is being consistent. Pick a routine — always with a light meal, always without food, whatever works for you — and stick to it every day. The one thing to avoid is...
  • Does it matter whether I take it with food or on an empty stomach?
📖 Read our full Aliskiren guide →

🕸️ Concept Web — How Aliskiren 300 MG Oral Tablet [Tekturna] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aliskiren 300 MG Oral Tablet [Tekturna] RxCUI 1011741

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Aliskiren 325646
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tekturna 700402
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aliskiren Oral Tablet 692500
    • Aliskiren Oral Product 1164887
    • Aliskiren Pill 1164888
    • Aliskiren Oral Tablet [Tekturna] 700404
    • Tekturna Oral Product 1180880
    • Tekturna Pill 1180881
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aliskiren 300 MG Oral Tablet SCD · 1011739
  • Aliskiren 300 MG SCDC · 1009314
  • Aliskiren Oral Tablet SCDF · 692500
  • Aliskiren Oral Product SCDG · 1164887
  • Aliskiren Pill SCDG · 1164888

Brand-Name Concepts

  • Aliskiren 300 MG [Tekturna] SBDC · 1011740
  • Aliskiren Oral Tablet [Tekturna] SBDF · 700404
  • Tekturna Oral Product SBDG · 1180880
  • Tekturna Pill SBDG · 1180881
  • Tekturna BN · 700402

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1011741 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70839-0150-30 30 TABLET, FILM COATED in 1 BOTTLE (70839-150-30) Tekturna LXO US Inc. 2017-01-01
70839-0300-30 30 TABLET, FILM COATED in 1 BOTTLE (70839-300-30) Tekturna LXO US Inc. 2017-01-01
Observed labelers: LXO US Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.